Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PEN Penumbra Inc
- Stocks
- Healthcare
- NYSE: PEN
Price (delayed)
$255.72
Market cap
$9.9B
P/E Ratio
232.47
Dividend/share
N/A
EPS
$1.1
Enterprise value
$9.75B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
Highlights
The price to earnings (P/E) is 42% lower than the last 4 quarters average of 398.1
PEN's revenue is up by 13% year-on-year and by 3.8% since the previous quarter
PEN's EPS has shrunk by 55% YoY
The net income has plunged by 55% YoY
Key stats
What are the main financial stats of PEN
Market
Valuations
Earnings
Shares outstanding
38.73M
Market cap
$9.9B
Enterprise value
$9.75B
Price to earnings (P/E)
232.47
Price to book (P/B)
8.12
Price to sales (P/S)
7.95
EV/EBIT
194.56
EV/EBITDA
136.71
EV/Sales
7.86
Revenue
$1.24B
Gross profit
$789.74M
Operating income
$37.53M
Net income
$42.23M
EBIT
$50.1M
EBITDA
$71.3M
Free cash flow
$150.33M
Per share
Balance sheet
Liquidity
EPS
$1.1
EPS diluted
$1.07
Free cash flow per share
$3.9
Book value per share
$31.49
Revenue per share
$32.16
TBVPS
$36.84
Total assets
$1.59B
Total liabilities
$380.43M
Debt
$220.66M
Equity
$1.21B
Working capital
$841.08M
Debt to equity
0.18
Current ratio
6.3
Quick ratio
3.45
Net debt/EBITDA
-2.18
Margins
Efficiency
Dividend
EBITDA margin
5.7%
Gross margin
63.7%
Net margin
3.4%
Operating margin
3%
Return on assets
2.8%
Return on equity
3.6%
Return on invested capital
4.5%
Return on capital employed
3.5%
Return on sales
4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PEN stock price
How has the Penumbra stock price performed over time
Intraday
0.5%
1 week
-0.09%
1 month
-4.77%
1 year
46.63%
YTD
7.68%
QTD
-4.37%
Financial performance
How have Penumbra's revenue and profit performed over time
Revenue
$1.24B
Gross profit
$789.74M
Operating income
$37.53M
Net income
$42.23M
Gross margin
63.7%
Net margin
3.4%
Penumbra's net margin has surged by 183% QoQ but it has shrunk by 60% YoY
PEN's operating margin has plunged by 58% YoY
The net income has plunged by 55% YoY
Penumbra's operating income has shrunk by 52% YoY
Price vs fundamentals
How does PEN's price correlate with its fundamentals
Growth
What is Penumbra's growth rate over time
Valuation
What is Penumbra stock price valuation
P/E
232.47
P/B
8.12
P/S
7.95
EV/EBIT
194.56
EV/EBITDA
136.71
EV/Sales
7.86
PEN's EPS has shrunk by 55% YoY
The price to earnings (P/E) is 42% lower than the last 4 quarters average of 398.1
The stock's P/B is 15% below its 5-year quarterly average of 9.6 but 11% above its last 4 quarters average of 7.3
PEN's equity is up by 5% since the previous quarter
PEN's price to sales (P/S) is 25% lower than its 5-year quarterly average of 10.6 but 10% higher than its last 4 quarters average of 7.2
PEN's revenue is up by 13% year-on-year and by 3.8% since the previous quarter
Efficiency
How efficient is Penumbra business performance
The ROE has soared by 200% from the previous quarter but it has plunged by 56% YoY
The company's return on invested capital has surged by 150% QoQ but it fell by 37% YoY
PEN's ROS has soared by 135% QoQ but it is down by 49% YoY
The ROA has plunged by 55% YoY
Dividends
What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PEN.
Financial health
How did Penumbra financials performed over time
Penumbra's quick ratio has increased by 7% QoQ and by 4.2% YoY
Penumbra's current ratio has increased by 4.8% from the previous quarter and by 2.9% YoY
Penumbra's debt is 82% lower than its equity
PEN's debt to equity is down by 5% since the previous quarter and by 5% year-on-year
Penumbra's debt has decreased by 4.7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.